Vnitr Lek 2019, 65(5):369-375 | DOI: 10.36290/vnl.2019.066

Nontuberculous mycobacterial disease: a case report-based review

Marcela Královcová1,*, Thomas Karvunidis1,2, Jaroslav Raděj1,2, Martin Matějovič1,2
1 I. interní klinika LF UK a FN Plzeň
2 Biomedicínské centrum LF UK v Plzni

Nontuberculous mycobacterial infections are rare diseases. However, as number of immunocompromised patients is growing and modern diagnostic tools are available, both the importance and incidence of nontuberculous mycobacterial infections are gaining clinical importance. Based on a clinical case, this article briefly summarizes the current knowledge on this issue.

Keywords: immunosuppression; nontuberculous mycobacteria

Received: August 17, 2018; Accepted: October 30, 2018; Published: May 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Královcová M, Karvunidis T, Raděj J, Matějovič M. Nontuberculous mycobacterial disease: a case report-based review. Vnitr Lek. 2019;65(5):369-375. doi: 10.36290/vnl.2019.066.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Atreya R, Bülte M, Gerlach GF et al. Facts, myths and hypotheses on zoonotic nature of Mycobacterium avium subspecies paratuberculosis. Int J Med Microbiol 2014; 304(7): 858-867. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijmm.2014.07.006>. Go to original source... Go to PubMed...
    2. Yoo JW, Jo KW, Kim SH et al. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. Transpl Int 2016; 29(5): 549-558. <http://dx.doi.org/10.1111/tri.12752>. Go to original source... Go to PubMed...
    3. Daley CL. Mycobacterium avium Complex Disease. Microbiol Spectr 2017; 5(2): 125-130. Dostupné z DOI: <http://dx.doi.org/10.1128/microbiolspec.TNMI7-0045-2017>. Go to original source... Go to PubMed...
    4. Winthrop KL, Baxter R, Liu L et el. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 2013; 72(1): 37-42. Dostupné z DOI: <http://dx.doi.org/10.1136/annrheumdis-2011-200690>. Go to original source... Go to PubMed...
    5. Marras TK, Campitelli MA, Kwong JC et al. Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease. Eur Respir J 2016; 48(3): 928-931. Dostupné z DOI: <http://dx.doi.org/10.1183/13993003.00033-2016>. Go to original source... Go to PubMed...
    6. Piersimoni C, Scarparo C. Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis 2009; 15(9): 1351-8; quiz 1544. Dostupné z DOI: <http://dx.doi.org/10.3201/eid1509.081259>. Go to original source... Go to PubMed...
    7. Stout JE, Koh WJ, Yew WW. Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis 2016; 45: 123-134. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijid.2016.03.006>. Go to original source... Go to PubMed...
    8. Murray R, Mallal S, Heath C et al. Cerebral mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis 2001; 20(3): 199-201. Go to original source... Go to PubMed...
    9. Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175(4): 367-416. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.200604-571ST>. Erratum in Am J Respir Crit Care Med. 2007 Apr 1; 175(7): 744-745. Go to original source... Go to PubMed...
    10. Bártů V. Doporučený postup pro diagnostiku a léčbu netuberkulózních mykobakterióz dospělých. Česká pneumologická a ftizeologická společnost ČLS JEP. 2016. Dostupné z WWW: <www.pneumologie.cz/guidelines/>.
    11. Haworth CS, Banks J, Capstick T et al. British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). BMJ Open Respir Res 2017; 4(1): e000242. Dostupné z DOI: <http://dx.doi.org/10.1136/bmjresp-2017-000242>. Go to original source... Go to PubMed...
    12. Khalid Ahmed Al-Anazi et al. Infections caused by non-tuberculosis mycobacteria in recipients of hematopoetic stem cell transplantation. Front Oncol 2014; 4: 311. Dostupné z DOI: <http://dx.doi.org/10.3389/fonc.2014.00311>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.